Developer docs
API playgroundTry for free, no card

Search company profiles

Central Link

Full company profile

uuid0028nad

Namestring
Central Link
Legal namestring
セントラルリンク株式会社
Websiteurl
centrallink.jp
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Central Link (セントラルリンク株式会社) is a Japanese specialty trading company (専門商社) operating in the pharmaceutical and biotechnology supply chain. The company's stated business is the procurement and distribution of diagnostic drug raw materials (診断薬原料) and bio raw materials (バイオ原料), serving manufacturers and developers in the diagnostics and biotechnology sectors on a B2B basis.

The company positions itself as a niche intermediary specializing in two adjacent raw-material categories — inputs for in-vitro diagnostic reagents and inputs for broader biotechnology applications — implying a customer base of diagnostic-reagent manufacturers, biotech firms, and potentially research institutions. The operating model follows the conventional Japanese specialty trading company structure: sourcing specialized materials from upstream suppliers and delivering them to downstream manufacturers, with value derived from supplier curation, quality assurance, and regulatory familiarity rather than from proprietary technology or brand.

The available source material provides no information on the company's revenue model, pricing mechanics, supplier network, customer count, headcount, geographic footprint beyond Japan, or financial ownership structure. The corporate website (centrallink.jp) is the only confirmed operating signal. Consequently, any investment-relevant assessment of scale, growth, or competitive position is constrained by a near-complete absence of disclosed operating data.

Short descriptiontext

Central Link (セントラルリンク株式会社) is a Japan-based B2B specialty trading company that sources and distributes diagnostic drug raw materials and bio raw materials to pharmaceutical and biotechnology manufacturers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersHachioji, Japan
HQ citystring
Hachioji
HQ countrystring
Japan
HQ regionstring
Asia
Markets served

Serves global market

Keyword5 values
diagnostic reagents trading, bio raw materials, pharmaceutical raw materials, specialty chemical distribution, life sciences trading
Industry2 codes
PRIMARYHLAIAJAO
Compounding Ingredient & API Distributors (Pharma Supply)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAGAGAI
Raw Materials & Critical Reagents Supply (Media/Resins/Cytokines)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
NAICS code1 code
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
SIC code1 code
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Specialty Pharmaceutical Raw Materials Trading
No data
Cost components4 values
Supply Chain, Operations, Personnel, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Central Link (セントラルリンク株式会社) operates as a specialty trading company (専門商社) that supplies diagnostic drug raw materials (診断薬原料) and bio raw materials (バイオ原料). The company serves manufacturers and organizations in the pharmaceutical and biotechnology sectors as a B2B intermediary sourcing and reselling these upstream inputs.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

セントラルリンク株式会社 (Central Link) is a specialty trading company dealing in diagnostic drug raw materials and bio raw materials. The company operates as a B2B specialty materials trader in the pharmaceutical and biotechnology sectors.

Product and service2 records
1Diagnostic drug raw materials (診断薬原料)
CategoryDiagnostic reagents / pharmaceutical raw materials
Description

Specialty raw materials used by diagnostic kit manufacturers and life sciences organizations as upstream inputs for diagnostic drug production.

2Bio raw materials (バイオ原料)
CategoryBio raw materials / life sciences inputs
Description

Specialty biological raw materials supplied to biotechnology and life sciences customers for use in research, development, and production applications.

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight1 record

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Japanese IVD and clinical chemistry reagents company with a global footprint. Comparable as a Japan-based specialist in diagnostic reagent manufacturing, operating in the same downstream vertical Central Link supplies into.

TypeDirect peer
Description

Japanese-headquartered specialty chemicals and reagents trader/manufacturer supplying pharma, diagnostic, and biotech raw materials globally. Directly comparable as a Japan-based specialty raw-materials intermediary in overlapping product categories.

TypeBroad incumbent
Description

Global life-science research and clinical diagnostics supplier of reagents and instruments. Comparable as a broad-line supplier of bio and diagnostic raw materials with established Japanese distribution.

TypeBroad incumbent
Description

Global incumbent in life-science raw materials and reagents. Comparable as the dominant broad-line distributor of bio and diagnostic raw materials that Central Link competes against in the Japan market.

TypeDirect peer
Description

Japanese specialty chemicals and reagents manufacturer/distributor serving pharma, electronics, and research customers. Comparable as a Japan-based raw-materials specialist with overlapping diagnostics/life-science product coverage.

TypeDirect peer
Description

Japan-based diagnostics and clinical chemistry reagents manufacturer. Comparable as a Japanese firm supplying inputs and reagents into the IVD/diagnostics value chain where Central Link distributes raw materials.

TypeBroad incumbent
Description

Global life-science tools and reagents giant serving diagnostics and biopharma manufacturers. Comparable as the incumbent benchmark for raw-material breadth, certification depth, and global distribution that Central Link must differentiate against.

TypeDirect peer
Description

Japanese specialty chemicals and diagnostic reagents supplier serving pharma and life-science customers. Comparable as a Japan-rooted supplier of diagnostic and bio raw materials to laboratory and IVD manufacturers.

TypeDirect peer
Description

Kyoto-based specialty chemicals, reagents, and life-science products supplier. Directly comparable as a Japanese specialty trader/manufacturer serving the diagnostic and bio research input markets.

TypeDirect peer
Description

Japanese specialty chemicals, biotech reagents, and diagnostics company. Comparable as a Japan-rooted multi-vertical supplier with diagnostic and bio raw materials exposure.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights3 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Central Link

Specialty Pharmaceutical Raw Materials Tradingcentrallink.jp

Central Link (セントラルリンク株式会社) is a Japan-based B2B specialty trading company that sources and distributes diagnostic drug raw materials and bio raw materials to pharmaceutical and biotechnology manufacturers.

What Central Link does

Central Link (セントラルリンク株式会社) is a Japanese specialty trading company (専門商社) operating in the pharmaceutical and biotechnology supply chain. The company's stated business is the procurement and distribution of diagnostic drug raw materials (診断薬原料) and bio raw materials (バイオ原料), serving manufacturers and developers in the diagnostics and biotechnology sectors on a B2B basis.

The company positions itself as a niche intermediary specializing in two adjacent raw-material categories — inputs for in-vitro diagnostic reagents and inputs for broader biotechnology applications — implying a customer base of diagnostic-reagent manufacturers, biotech firms, and potentially research institutions. The operating model follows the conventional Japanese specialty trading company structure: sourcing specialized materials from upstream suppliers and delivering them to downstream manufacturers, with value derived from supplier curation, quality assurance, and regulatory familiarity rather than from proprietary technology or brand.

The available source material provides no information on the company's revenue model, pricing mechanics, supplier network, customer count, headcount, geographic footprint beyond Japan, or financial ownership structure. The corporate website (centrallink.jp) is the only confirmed operating signal. Consequently, any investment-relevant assessment of scale, growth, or competitive position is constrained by a near-complete absence of disclosed operating data.

Central Link firmographics

Firmographics
Name
Central Link
Legal name
セントラルリンク株式会社
Website
https://centrallink.jp
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
1–10 employees
Short description
Central Link (セントラルリンク株式会社) is a Japan-based B2B specialty trading company that sources and distributes diagnostic drug raw materials and bio raw materials to pharmaceutical and biotechnology manufacturers.
Ownership category
akta.pro rank

Central Link industry classification

Industry
Product category
Specialty Pharmaceutical Raw Materials Trading
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (424210)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAIAJAO
Compounding Ingredient & API Distributors (Pharma Supply)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAGAGAI
Raw Materials & Critical Reagents Supply (Media/Resins/Cytokines)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)

Keywords

  • Diagnostic reagents trading
  • Bio raw materials
  • Pharmaceutical raw materials
  • Specialty chemical distribution
  • Life sciences trading

Where Central Link is headquartered

Location

Headquarters

HQ city
Hachioji
HQ country
Japan
HQ region
Asia

Markets served

Central Link business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales

Central Link product offering

Product offering

Core offering

Central Link (セントラルリンク株式会社) operates as a specialty trading company (専門商社) that supplies diagnostic drug raw materials (診断薬原料) and bio raw materials (バイオ原料). The company serves manufacturers and organizations in the pharmaceutical and biotechnology sectors as a B2B intermediary sourcing and reselling these upstream inputs.

Product overview

セントラルリンク株式会社 (Central Link) is a specialty trading company dealing in diagnostic drug raw materials and bio raw materials. The company operates as a B2B specialty materials trader in the pharmaceutical and biotechnology sectors.

Differentiator

Problem solved

Functional benefit

Products and services

  • Diagnostic drug raw materials (診断薬原料) Specialty raw materials used by diagnostic kit manufacturers and life sciences organizations as upstream inputs for diagnostic drug production.
  • Bio raw materials (バイオ原料) Specialty biological raw materials supplied to biotechnology and life sciences customers for use in research, development, and production applications.

Companies that use Central Link

Customer profile

Ideal customer profiles1 record

Central Link technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Central Link partnerships and signals

Strategic signal

Recent moves1 record

Expansion highlights1 record

Central Link competitors and assessment

Company assessment

Direct peers

  • Eiken Chemical: Japanese IVD and clinical chemistry reagents company with a global footprint. Comparable as a Japan-based specialist in diagnostic reagent manufacturing, operating in the same downstream vertical Central Link supplies into.
  • Tokyo Chemical Industry (TCI): Japanese-headquartered specialty chemicals and reagents trader/manufacturer supplying pharma, diagnostic, and biotech raw materials globally. Directly comparable as a Japan-based specialty raw-materials intermediary in overlapping product categories.
  • Kanto Chemical: Japanese specialty chemicals and reagents manufacturer/distributor serving pharma, electronics, and research customers. Comparable as a Japan-based raw-materials specialist with overlapping diagnostics/life-science product coverage.
  • Sekisui Medical: Japan-based diagnostics and clinical chemistry reagents manufacturer. Comparable as a Japanese firm supplying inputs and reagents into the IVD/diagnostics value chain where Central Link distributes raw materials.
  • Fujifilm Wako Pure Chemical: Japanese specialty chemicals and diagnostic reagents supplier serving pharma and life-science customers. Comparable as a Japan-rooted supplier of diagnostic and bio raw materials to laboratory and IVD manufacturers.
  • Nacalai Tesque: Kyoto-based specialty chemicals, reagents, and life-science products supplier. Directly comparable as a Japanese specialty trader/manufacturer serving the diagnostic and bio research input markets.
  • Toyobo: Japanese specialty chemicals, biotech reagents, and diagnostics company. Comparable as a Japan-rooted multi-vertical supplier with diagnostic and bio raw materials exposure.

Broad incumbents

  • Bio-Rad Laboratories: Global life-science research and clinical diagnostics supplier of reagents and instruments. Comparable as a broad-line supplier of bio and diagnostic raw materials with established Japanese distribution.
  • Sigma-Aldrich (Merck KGaA Life Science): Global incumbent in life-science raw materials and reagents. Comparable as the dominant broad-line distributor of bio and diagnostic raw materials that Central Link competes against in the Japan market.
  • Thermo Fisher Scientific: Global life-science tools and reagents giant serving diagnostics and biopharma manufacturers. Comparable as the incumbent benchmark for raw-material breadth, certification depth, and global distribution that Central Link must differentiate against.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights3 records

Customer concentration

Central Link financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Central Link leadership team

Management profile

Number of profiles

Central Link funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Central Link M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Central Link

What does Central Link do?

Central Link (セントラルリンク株式会社) operates as a specialty trading company (専門商社) that supplies diagnostic drug raw materials (診断薬原料) and bio raw materials (バイオ原料). The company serves manufacturers and organizations in the pharmaceutical and biotechnology sectors as a B2B intermediary sourcing and reselling these upstream inputs.

Is Central Link a public or private company?

Central Link is a private company. It is classified as unknown and is currently operating.

When was Central Link founded?

Central Link was founded in 2020. It employs 1 to 10 people.

Where is Central Link based?

Central Link is headquartered in Hachioji, Japan, in the Asia region.

Who are Central Link's main competitors?

Direct peers on record are Eiken Chemical, Tokyo Chemical Industry (TCI), Kanto Chemical, Sekisui Medical, Fujifilm Wako Pure Chemical, Nacalai Tesque and Toyobo. Broad incumbents are Bio-Rad Laboratories, Sigma-Aldrich (Merck KGaA Life Science) and Thermo Fisher Scientific.

Does Central Link have an API?

No public API is recorded for Central Link.

What industry is Central Link in?

Central Link's product category is Specialty Pharmaceutical Raw Materials Trading. Its primary akta.pro industry code is HLAIAJAO, Compounding Ingredient & API Distributors (Pharma Supply), with a secondary code of HLAGAGAI, Raw Materials & Critical Reagents Supply (Media/Resins/Cytokines). Its NAICS code is 424210 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales